Multiple sclerosis trials in Portugal

1 of 17 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  Ofatumumab in Portuguese Multiple Sclerosis Patients - an Observational Study

  Where

  Amadora, Guimarães, Leiria, Lisbon, Matosinhos Municipality, Ponte de Lima, Porto, Setúbal

  Age

  18 years to 99 years

  People

  174

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT05809986